D. P. Sichinava

D. P. Sichinava

Auto-generated profile, based on publicly available information

D. P. Sichinava

City Polyclinic № 9

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2024 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
SMS. Yu. Martsevich
S. Yu. Martsevich
OAO. S. Afonina
O. S. Afonina
АЗА. В. Загребельный
А. В. Загребельный
DSD. P Sichinava
D. P Sichinava
ISI. V. Samorodskaya
I. V. Samorodskaya
СМС. Ю. Марцевич
С. Ю. Марцевич
Aim. To compare the long-term prognosis of life of patients after primary and recurrent acute myocardial infarction (MI).Material and methods. The study was based on the RIMIS registry, which included all patients after transmural MI in 2017 in one of the Moscow vascular centers. The prospective part included 191 patients who survived the acute stage of MI, of which 145 suffered a primary acute MI, 46 — a recurrent acute MI. Long-term follow-up data were collected 71 (53;75) months after discharge from the hospital. The primary endpoint was any-cause death.Results. During the follow-up period, 35 (25,2%) patients with a primary MI and 25 (64,1%) patients with a recurrent MI died (p<0,001). It was not possible to establish the fate of 13 (6,81%) patients, of which 7 (4,83%) were people with primary MI and 6 (13,04%) people with recurrent MI. The death risk was significantly higher in patients who had a recurrent MI compared to patients who had a primary MI: hazard ratio (HR)=3,52 (2,09;5,96), p<0,001). An unfavorable prognosis was determined not by the fact of a recurrent MI, but by the complications that resulted from a previous MI, primarily heart failure, as well as age, sex, smoking status, and hospitalizations for cardiovascular diseases in the year before the reference MI, history of angina and following comorbidities: a prior stroke, major bleeding (life-threatening gastrointestinal bleeding requiring complex surgical intervention). Patients who had a recurrent MI were significantly more adherent to follow-up and prescribed therapy.Conclusion. Despite the modern strategy for treating MI both in the acute stage and in the long-term period, the prognosis after recurrent MI remains unfavorable. Signs negatively affecting the prognosis were sex, age, a history of heart failure and angina pectoris, and hospitalizations for cardiovascular diseases one year prior to reference MI.

7 March 2023 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
EKE. P. Kalaydzhyan
E. P. Kalaydzhyan
NKN. P. Kutishenko
N. P. Kutishenko
YLYulia Lukina
Yulia Lukina
DSD. P. Sichinava
D. P. Sichinava
SMS. Yu. Martsevich
S. Yu. Martsevich
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. To assess adherence to the recommended therapy at the stage of outpatient follow-up and its impact on long-term outcomes in patients after acute myocardial infarction based on the materials of the prospective PROFILE-IM registry.Material and methods. The PROFILE-IM register included 160 patients who applied to one of the polyclinics in Moscow after a myocardial infarction. The combined endpoint (CE) included death from any cause, cardiovascular events (nonfatal myocardial infarction, nonfatal cerebral stroke), emergency hospitalizations for cardiovascular diseases, significant cardiac arrhythmias. Patients' adherence to therapy was assessed using the original questionnaire "Scale of Adherence of the National Society of Evidence-based Pharmacotherapy" (NODF) and a direct standardized patient survey by a doctor about taking medications. Visits to the doctor were carried out every two months, data from the first year of patient follow-up are presented.Results. In a personal interview with a doctor, the ratio of the proportion of committed, partially committed and non-committed patients did not change significantly over the entire follow-up period, while the proportion of committed patients was 81-85%. The "NODF Adherence Scale" showed that the proportion of non-committed patients was about 10 times higher than with direct patient responses to the doctor, and the proportion of non-committed and partially committed patients remained high at all stages of follow-up (respectively 28% and 10% at the beginning of the study, 18% and 10% at the end of the study). Among the main factors of non-commitment, there was a decrease in the importance of forgetfulness and an increase in factors such as fear of side effects of medications, doubt about the need for long-term use of medications and well-being. A direct relationship of adherence with the male sex, the presence of hypertension, a feedback relationship with alcohol consumption was revealed. The risk of CE in non-committed patients was higher compared to the group of committed and partially committed patients (p<0.01).Conclusion. The proportion of non-committed and partially committed patients remained high at all stages of follow-up. There was a direct relationship between adherence to therapy with the male sex, the presence of hypertension in the anamnesis, and a feedback relationship with alcohol consumption. Low adherence to therapy significantly increased the risk of cardiovascular events.

22 September 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
SMS. Yu. Martsevich
S. Yu. Martsevich
АЗА. В. Загребельный
А. В. Загребельный
NZN. P. Zolotareva
N. P. Zolotareva
MGM. L. Ginzburg
M. L. Ginzburg
ИКИ. М. Кузьмина
И. М. Кузьмина
СМС. Ю. Марцевич
С. Ю. Марцевич
Aim. To compare the long-term survival of patients after primary and recurrent myocardial infarction (MI) in the LIS-3 and RIMIS registries.Material and methods. The retrospective RIMIS registry included patients with acute transmural MI admitted to the emergency cardiology department of one of the Moscow vascular centers in 2017. A total of 214 patients were included, of which 23 people died in hospital and 191 people were included in the prospective registry part. Long-term vital status was assessed on average 6 years after discharge from hospital and was determined in 178 patients. The response rate was 93,19%. The prospective registry LIS-3 included all patients admitted to the Lyubertsy Regional Hospital with a diagnosis of acute coronary syndrome, of which 78 patients were discharged after confirmed MI in the first 9 months of 2014, and 164 patients were discharged after confirmed MI in the first 9 months of 2018. A total of 242 patients were included. Long-term vital status was determined in 207 patients. The response rate 85,5%. The median follow-up was 872 days. Comparative analysis of patient cohorts from the RIMIS and LIS-3 registries did not reveal any significant differences in the main demographic, anamnestic, and clinical parameters. The frequency of percutaneous coronary intervention in the acute stage of MI was higher in the RIMIS registry than in the LIS-3 registry (96,9 and 62,3%, respectively).Results. During the follow-up period, 31,4% of patients died in the RIMIS registry, and 20,8% of patients in the LIS-3 registry. Kaplan-Meier curves did not reveal any significant differences in patient survival in both registries. At the same time, in both registries, the long-term survival of patients after recurrent MI was significantly worse than that of patients who had a primary MI.Conclusion. Patients who had an acute MI, despite modern treatment in the acute stage, have a high residual risk of death. This is especially true for patients who had a recurrent MI.

1 December 2024 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
OAO. S. Afonina
O. S. Afonina
SMS. Yu. Martsevich
S. Yu. Martsevich
AZA. V. Zagrebelnyy
A. V. Zagrebelnyy
DSD. P. Sichinava
D. P. Sichinava
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. Among patients who survived acute myocardial infarction (MI) with ST segment elevation (STEMI), to assess gender differences in clinical and anamnestic indicators, long-term survival, as well as factors affecting it. To compare the effect of recurrent MI on long-term survival in men and women.Material and methods. Data from the retro-prospective RIMIS register were used. In 2017, 214 patients with STEMI were admitted to the emergency cardiology department of the vascular center, 23 (10.8%) of them died in the hospital. After 6 years, the life status of patients discharged from the hospital was assessed (191 people, 129 men, 62 women). The response was 93.2%. The factors influencing the fatal outcome were assessed using a model of proportional Coke risks separately for men and women. The primary endpoint was the overall patient’s mortality.Results. The women who survived MI were, on average, 16.5 years older than the men who survived, and they were more likely to have concomitant diseases (diabetes mellitus, obesity). During the follow-up period, 34 men (26.4%) and 26 women (41.9%) died. Kaplan-Meyer curves demonstrated significantly worse survival in women compared to men. However, after the age adjustment was introduced, the risk of death in women was lower than in men (HR =0.981 (0.968-0.993), p=0.003). The main mortality predictors in women were hospitalization before reference MI, a history of coronary heart disease, a history of cerebral stroke, and anemia. In men, the main predictor of death was the presence of disability, the fact of recurrent MI, a history of chronic kidney disease and the presence of oncology (the latter two factors were rare, respectively, in 6.2% and 3.9% of patients).Conclusion. Women suffered MI much later than men. Therefore, higher mortality rates after MI were mainly determined by concomitant diseases. The main mortality predictor in men was recurrent MI. The age-adjusted risk of death after MI is lower in women than in men.

20 April 2025 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
EKE. P. Kalaidzhyan
E. P. Kalaidzhyan
NKN. P. Kutishenko
N. P. Kutishenko
YLYulia Lukina
Yulia Lukina
DSD. P. Sichinava
D. P. Sichinava
SMS. Yu. Martsevich
S. Yu. Martsevich
СМС. Ю. Марцевич
С. Ю. Марцевич
Aim. To assess the quality of treatment of patients with myocardial infarction (MI) and early carbohydrate metabolism disorders as part of outpatient follow-up.Material and methods. The study was conducted within the outpatient registry of patients after myocardial infarction PROFILE-MI, which included all patients who visited a cardiologist at Moscow City Polyclinic № 9 after myocardial infarction from March 1, 2014 to June 30, 2015. A total of 160 people were included as follows: 106 (66,2%) men and 54 (33,8%) women; mean age, 70,4±10,8 (from 39 to 87) years. Visits were carried out every 2 months. Fasting plasma glucose levels were assessed. The follow-up lasted 1 year. Patients with carbohydrate metabolism disorders 68 (42,5%) were divided into 3 following groups: 1: patients with a history of type 2 diabetes (T2D) or diagnosed at the inpatient stage — 45 (28%); 2: patients with a history of impaired glucose tolerance (IGT) or diagnosed at the inpatient stage — 6 (4%); 3: patients without T2D or IGT (n=109), in whom impaired fasting glycemia was recorded for the first time at the outpatient stage — 17 (16%). The prescription rate of metformin was assessed in all groups.Results. There were 23 (14,4%) patients with early carbohydrate metabolism disorders included in the registry. In group 3, there were significantly more men than in groups 1 and 2 — 76,5 vs 42 and 33% (p<0,001), and the mean age of 59,8±11,9 years was lower — 64,04±11,4 and 72,5±6,8 years (p=0,033), respectively. In this group, there were no smoking patients (p=0,007), fewer obese patients (18 vs 44 and 33%), but more overweight individuals compared to group 1 (47 vs 40%). In addition, burdened heredity (47 vs 64 and 67%), hypertension (65 vs 84 and 100%) were less frequently registered, respectively. The proportion of patients with a history of coronary artery disease was lower in group 3 compared to group 1 and amounted to 29 vs 47% (p=0,012). During the follow-up period, the prevalence of blood glucose testing did not exceed 44%. Metformin was prescribed only to patients of group 1 upon discharge from the hospital — 3 (6,7%), while metformin therapy was not prescribed to patients of groups 2 and 3. Conclusion. According to the PROFILE-MI registry, the total prevalence of early carbohydrate metabolism disorders among patients with a history of MI was quite high and amounted to 14,4%. This category of patients had a less complicated cardiovascular history. In real-world practice, metformin was not prescribed to patients with early carbohydrate metabolism disorders.